Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objectives are: - To evaluate the efficacy of IV induction regimens of Ustekinumab in inducing clinical response in subjects with moderately to severely active Crohn’s disease. - To evaluate the safety of IV induction regimens of Ustekinumab in subjects with moderately to severely active Crohn’s disease.
Critère d'inclusion
- Moderately-to-Severely Active Crohn’s Disease